Public Health England garners award for Ebola relief efforts
PHE’s award recognized its leadership as well as its contribution to developing therapeutics, vaccines, and diagnostics. The organization received the award at the RCUK and Praxis Unico Impact Awards in London, U.K. The awards ceremony acknowledged the Knowledge Exchange and Commerialization Team at PHE and how the team united expertise from a variety of organizations as well as individual experts. This enabled the organization to handle the largest Ebola outbreak in history.
“We are delighted to have been selected as the winner under 'Contribution to Society' from a list of equally deserving projects,” David Rhodes, head of business development at Public Health England (PHE), said. “This recognition is a tribute not only to the activities of the Business Development team but the wider work of Public Health England during the international response to Ebola. We are honored that our work has been recognized by the U.K. Research Councils and our professional body PraxisUnico, alongside the range of other awards won by our colleagues across PHE. We believe that our robust, prompt and fair way of exchanging knowledge with industry, academia and other public bodies, greatly enhanced the effectiveness of the U.K. response.”
The Public Health England updates also included information about the worldwide burden of disease study, cancer diagnosis occurring earlier, PHE supporting life science forums, the U.K. government investing in the new Harlow laboratories, Porton Biopharma Ltd forming and how E-cigarettes can help smokers quit smoking.